Home Article Swine Flu and its Risk Management

Review Article

Swine Flu and its Risk Management


Verma, S., Kumar, M., Sharma, V.K., Easwari, T.S.

Author's Affiliation


The H1N1 flu virus (referred to as “swine flu” early on) is a new influenza virus strain that is causing illness in people. Swine flu has been confirmed in a number of countries. This new virus strain was first detected in people in the US in April 2009 and is spreading from person-to-person worldwide, probably in much the same way that regular seasonal influenza viruses spread. On June 11, 2009, the World Health Organization (WHO) declared that a pandemic of H1N1 flu was underway. The scientists say this is a “quadruple reassortant” virus. This is a dangerous scenario in the 21st century. In India day by day the graph of infected person has been climbed up so, it is important to take into consideration about this disease as it may prove deadly one. Currently available drugs like neuraminidase inhibitors such as Tamiflu (oseltamivir), Zanamivir like antivirals have potential and resistance problem. This article collects the information about the recommended available drugs and herbal therapy like Sambucus nigra, Wasabia japonica, tuberosum and Solanum tuberosum ssp. andigena and various immune enchancers like Ocimum sanctum, Glycyrrhiza glabra, Allium sativum, Melissa officinalis etc. This article collects the brief information about this particular disease and about their method of prevention which directly or indirectly provides help to the peoples of various countries.


H1N1, Swine flu, Quadruple reassortant, Tamiflu

Cite This Article

Verma, S., Kumar, M., Sharma, V. K., & Easwari, T. S. (2017). Swine Flu and its Risk Management, International Journal for Pharmaceutical Research Scholars (IJPRS), 6(4), 25-36.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Articles